Clinical Trials Directory

Trials / Unknown

UnknownNCT02678078

Characterization of Cancer Tissue Using 3D Biosynthetic Material

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Technion, Israel Institute of Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from stage 4 cancer patients, the investigators will evaluate and characterize the metastatic cells.

Detailed description

The investigators' biomaterial lab has developed an in vitro diagnostic system in which a cancer tumor is placed inside a 3D hydrogel. This material has similar properties to the human tissue and can visualize cell migration and proliferation. In this system, the investigators have already characterised human metastatic cells obtained from nude mice tumors. The diagnostic assay is able to evaluate the reduction in cell growth associated with anti-cancer drug therapy. The next step is to test the in vitro diagnostic system using human tissue samples from human patients, and to validate the system as a simple and effective a priori diagnostic tool for characterizing patient tumours.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnalyzing biopsy samplesAnalyzing biopsy samples that is preformed as part of the patient treatment.

Timeline

Start date
2016-02-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2016-02-09
Last updated
2016-05-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02678078. Inclusion in this directory is not an endorsement.